Morguard (TSE:MRC – Get Free Report) released its quarterly earnings data on Wednesday. The real estate investment trust reported C$8.00 earnings per share for the quarter, FiscalAI reports. Morguard had a return on equity of 4.61% and a net margin of 18.49%. The business had revenue of C$282.20 million for the quarter.
Morguard Stock Performance
Shares of MRC stock opened at C$109.30 on Friday. The company has a debt-to-equity ratio of 123.43, a quick ratio of 0.13 and a current ratio of 0.42. The company has a market capitalization of C$1.17 billion, a P/E ratio of 5.67 and a beta of 0.11. The company’s 50 day moving average price is C$113.48 and its two-hundred day moving average price is C$116.92. Morguard has a 52 week low of C$108.70 and a 52 week high of C$127.40.
Insiders Place Their Bets
In related news, insider Sime Armoyan purchased 34,200 shares of Morguard stock in a transaction dated Monday, August 31st. The stock was bought at an average price of C$104.30 per share, for a total transaction of C$3,567,060.00. Following the completion of the acquisition, the insider directly owned 1,456,223 shares of the company’s stock, valued at C$151,884,058.90. This represents a 2.41% increase in their ownership of the stock. Insiders have purchased a total of 71,900 shares of company stock valued at $7,880,585 over the last 90 days. Insiders own 72.99% of the company’s stock.
Morguard Company Profile
Morguard Corporation is a real estate investment company listed on the Toronto Stock Exchange (TSX: MRC). The company and its subsidiaries, Morguard REIT (TSX: MRT.UN) and Morguard North American Residential REIT (TSX: MRG.UN), own a diversified portfolio of real estate assets across multiple classes, including office, industrial, retail, multi-suite residential and hotel. Morguard also provides real estate management services to institutional and other investors. As at September 30, 2025, Morguard’s owned and managed portfolio of assets was valued at $19 billion.
Read More
- Five stocks we like better than Morguard
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Morguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morguard and related companies with MarketBeat.com's FREE daily email newsletter.
